NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
11.13
+0.75 (7.23%)
At close: Jun 18, 2026, 4:00 PM EDT
11.44
+0.31 (2.75%)
After-hours: Jun 18, 2026, 7:02 PM EDT

NeoGenomics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, NeoGenomics stock has a consensus rating of "Buy" and an average price target of $15.06. The average 1-year stock price forecast is 35.31% higher than the current stock price, while the lowest is $11 (-1.17%) and the highest is $25 (+124.62%).

Price Target: $15.06 (+35.31%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$11$15.06$14$25
Change-1.17%+35.31%+25.79%+124.62%
* Price targets were last updated on Apr 30, 2026.

Analyst Ratings

The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy444666
Buy222222
Hold777444
Sell000000
Strong Sell000000
Total131313121212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
William Blair
William Blair
Hold
Maintains
n/a
HoldMaintainsn/an/aMay 27, 2026
BTIG
BTIG
Hold
Reiterates
n/a
HoldReiteratesn/an/aApr 30, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$13
BuyReiterates$13+16.80%Apr 30, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
$13$11
HoldMaintains$13$11-1.17%Apr 29, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
n/a
BuyMaintainsn/an/aApr 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
800.44M
from 727.33M
Increased by 10.05%
Revenue Next Year
880.69M
from 800.44M
Increased by 10.03%
EPS This Year
0.18
from 0.12
Increased by 50.00%
EPS Next Year
0.36
from 0.18
Increased by 102.53%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
484.33M509.73M591.64M660.57M727.33M800.44M
Revenue Growth
8.97%5.24%16.07%11.65%10.11%10.05%
Gross Profit
187.06M187.90M244.60M290.10M313.89M357.49M
Gross Margin
38.62%36.86%41.34%43.92%43.16%44.66%
Operating Income
-118.75M-153.11M-96.65M-71.10M-69.65M-64.33M
Net Income
-8.35M-144.25M-87.97M-78.73M-108.03M-57.81M
EPS
----0.120.18
EPS Growth
----9.09%50.00%
Forward PE
---103.9183.5861.83
Free Cash Flow
-64.72M-30.50M-272.88K-1.93M17.20M23.01M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High802.7M
Avg800.4M
Low798.8M

Revenue Growth

Revenue Growth202620272028
High
10.4%
Avg
10.1%
Low
9.8%

EPS Forecast

EPS202620272028
High0.27
Avg0.18
Low0.14

EPS Growth

EPS Growth202620272028
High
125.0%
Avg
50.0%
Low
16.7%